SERPINA4 and triple-A syndrome: Since ROS and cell apoptosis are implicated in AAA, stimulating kallistatin to upregulate NO production and limit cell apoptosis could be a potential target for therapy for AAA (Figure 1) [19,24,26,27,42,43,44,54,56,59,60,61,62,63,64].